TRMED (Thor Medical ASA) vs Oslo OBX Comparison

TRMED

Oslo OBX

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

TRMED

Oslo OBX

Difference

1Y 3Y 5Y 10Y 15Y 20Y

TRMED

Oslo OBX

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Oslo OBX

TRMED

ABBV

AMGN

GILD

VRTX

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Thor Medical ASA
Glance View

Market Cap

582.5m NOK

Industry

Biotechnology

Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The company is headquartered in Oslo, Oslo and currently employs 16 full-time employees. The company went IPO on 2014-07-07. The firm is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product is Betalutin, a CD37-targeting radio-immunoconjugate designed to advance the treatment of non-Hodgkin lymphoma (NHL). Betalutin uses monoclonal antibodies to attack the cancer cells in two ways, first as an immunotherapy and secondly as a targeting agent for a radioactive payload and is a combination of radiation therapy and immunotherapy. The firm is also leveraging its expertise in radionuclides and CD37-targeting antibodies, along with partners, to build a pipeline of biopharmaceuticals for a range of haematological cancers.

View TRMED Analysis

TRMED Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

FR		Pharnext SCA OTC:PNEXF	Add
US		Abbvie Inc NYSE:ABBV	Add
US		Amgen Inc NASDAQ:AMGN	Add
US		Gilead Sciences Inc NASDAQ:GILD	Add
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Add
US	E	Epizyme Inc F:EPE	Add
AU		CSL Ltd ASX:CSL	Add
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	Add
US	S	Seagen Inc F:SGT	Add
NL		argenx SE XBRU:ARGX	Add

FR		Pharnext SCA OTC:PNEXF	Select
US		Abbvie Inc NYSE:ABBV	Select
US		Amgen Inc NASDAQ:AMGN	Select
US		Gilead Sciences Inc NASDAQ:GILD	Select
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Select
US	E	Epizyme Inc F:EPE	Select
AU		CSL Ltd ASX:CSL	Select
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	Select
US	S	Seagen Inc F:SGT	Select
NL		argenx SE XBRU:ARGX	Select

FR		Pharnext SCA OTC:PNEXF	Add
US		Abbvie Inc NYSE:ABBV	Add
US		Amgen Inc NASDAQ:AMGN	Add
US		Gilead Sciences Inc NASDAQ:GILD	Add
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Add
US	E	Epizyme Inc F:EPE	Add
AU		CSL Ltd ASX:CSL	Add
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	Add
US	S	Seagen Inc F:SGT	Add
NL		argenx SE XBRU:ARGX	Add

HR	C	CROBEX INDX:CRBEX	Add
SA	T	Tadawul All Share INDX:TASI	Add
TH	S	SET Index INDX:SET	Add
ID	J	Jakarta Composite Index INDX:JKSE	Add
GR	A	Athens General Composite INDX:ATG	Add
BR	B	BOVESPA INDX:BVSP	Add
AR	S	S&P Merval INDX:MERV	Add
MX	M	Mexico S&P/BMV IPC INDX:MXX	Add
CZ	P	PX Prague Stock Index INDX:PX	Add
RU	M	MOEX Russia INDX:IMOEX	Add

	Franklin Covey Co NYSE:FC	35.3 USD 0.17%
	Mohawk Industries Inc NYSE:MHK	118.28 USD 0.84%
	Ardmore Shipping Corp NYSE:ASC	12.56 USD -1.64%
	ASGN Inc NYSE:ASGN	86.92 USD 0.67%
	Skyworks Solutions Inc NASDAQ:SWKS	92.63 USD -0.03%
	Weatherford International PLC NASDAQ:WFRD	72.13 USD -3.57%

TRMED

vs

Oslo OBX

Stocks Performance
TRMED vs Oslo OBX

Performance Gap
TRMED vs Oslo OBX

Performance By Year
TRMED vs Oslo OBX

Competitors Performance
Thor Medical ASA vs Peers

Thor Medical ASA
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	142.27 USD -2.71%
	Bank of America Corp NYSE:BAC	46.21 USD 0.28%
	Mastercard Inc NYSE:MA	516.4 USD 0.98%
	Salesforce Inc NYSE:CRM	326.9 USD 0.61%
	Abbvie Inc NYSE:ABBV	178.5 USD -0.57%
	Home Depot Inc NYSE:HD	387.2 USD 0.77%

	Arista Networks Inc NYSE:ANET	115.51 USD 0.19%
	Visa Inc NYSE:V	312.6 USD 0.3%
	Texas Pacific Land Corp NYSE:TPL	1 275.94 USD 1.4%
	KLA Corp NASDAQ:KLAC	686.2 USD -0.45%
	Manhattan Associates Inc NASDAQ:MANH	272.49 USD 1.6%
	Pinduoduo Inc NASDAQ:PDD	100.32 USD -0.3%

	Salesforce Inc NYSE:CRM	326.9 USD 0.61%
	ServiceNow Inc NYSE:NOW	1 049.08 USD -0.48%
	EOG Resources Inc NYSE:EOG	128.46 USD 0.71%
	Copart Inc NASDAQ:CPRT	56.78 USD 0.96%
	Applied Materials Inc NASDAQ:AMAT	176.99 USD -0.47%
	Synopsys Inc NASDAQ:SNPS	502 USD 2.95%

	Johnson & Johnson NYSE:JNJ	142.27 USD -2.71%
	Berkshire Hathaway Inc NYSE:BRK.A	677 925 USD -0.09%
	Bank of America Corp NYSE:BAC	46.21 USD 0.28%
	Mastercard Inc NYSE:MA	516.4 USD 0.98%
	UnitedHealth Group Inc NYSE:UNH	524.52 USD 2%
	Exxon Mobil Corp NYSE:XOM	106.93 USD -1.67%

TRMED vs Oslo OBX

Stocks Performance TRMED vs Oslo OBX

Performance Gap TRMED vs Oslo OBX

Performance By Year TRMED vs Oslo OBX

Competitors Performance Thor Medical ASA vs Peers

Thor Medical ASA Glance View

Company

Help

Tools

Stocks

TRMED

vs

Oslo OBX

Stocks Performance
TRMED vs Oslo OBX

Performance Gap
TRMED vs Oslo OBX

Performance By Year
TRMED vs Oslo OBX

Competitors Performance
Thor Medical ASA vs Peers

Thor Medical ASA
Glance View